Global Impetigo Therapeutic Market reached US$ 532.0 million in 2023 and is expected to reach US$ 931.86 million by 2031, growing at a CAGR of 7.4% during the forecast period 2024-2031. Impetigo is a common infection of the superficial layers of the epidermis that is highly contagious and most commonly caused by gram-positive bacteria.